Xenon PharmaceuticalsXENE
13F holders, Q3 2024 (September 30)203holders −10
13new positions
24sold out
7famous investors
$39.39avg. 13F price*
At the end of Q3 2024, 203 institutions reported holding Xenon Pharmaceuticals Inc. (XENE) in their 13F filings, down 10 from Q2 2024. 13 opened new positions and 24 sold out. The largest holders were FMR LLC ($272.3M), Avoro Capital Advisors LLC ($223.1M) and Driehaus Capital Management LLC ($180.9M). 7 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
- Company
- Xenon Pharmaceuticals Inc.
- CUSIP
- 98420N105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $15.5M |
| Exits | 24 | $139.3M |
All 13F filers, Q2 2024 → Q3 2024: 5,797,892 shares bought and 5,831,391 shares sold, net −33,499 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 203 holders
| FMR LLC | 0.02% | Add +2.2% | 6,917,684 | $272.3M |
| Avoro Capital Advisors LLC | 3.25% | No change | 5,666,666 | $223.1M |
| Driehaus Capital Management LLC | 1.55% | Add +4.0% | 4,595,721 | $180.9M |
| Wellington Management Group LLP | 0.03% | Add +0.4% | 3,843,447 | $151.3M |
| Braidwell LP | 4.59% | Add +5.7% | 2,707,255 | $106.6M |
| Commodore Capital LP | 6.64% | Reduce -2.0% | 2,700,000 | $106.3M |
| Capital World Investors | 0.02% | No change | 2,681,537 | $105.6M |
| Capital International Investors | 0.02% | Add +4.3% | 2,581,172 | $101.6M |
| Janus Henderson Group PLC | 0.05% | Add +144.2% | 2,552,392 | $100.5M |
| Polar Capital Holdings Plc | 0.46% | Reduce -3.6% | 2,444,645 | $96.2M |
| BlackRock, Inc. | 0.00% | — | 2,105,562 | $82.9M |
| Adage Capital Partners Gp, L.L.C. | 0.14% | Add +13.3% | 2,083,972 | $82.0M |
| Pictet Asset Management Holding SA | 0.07% | Add +3.3% | 1,528,814 | $60.2M |
| T. Rowe Price Investment Management, Inc. | 0.04% | Add +4.4% | 1,503,808 | $59.2M |
| Alliancebernstein L.P. | 0.02% | Reduce -3.9% | 1,424,735 | $56.1M |
| Rock Springs Capital Management LP | 1.69% | Add +3.4% | 1,316,477 | $51.8M |
| Marshall Wace, LLP | 0.06% | Reduce -13.7% | 1,195,480 | $47.1M |
| First Light Asset Management, LLC | 3.87% | Reduce -9.5% | 1,181,662 | $46.5M |
| Affinity Asset Advisors, LLC | 7.49% | Add +15.1% | 1,144,021 | $45.0M |
| Samlyn Capital, LLC | 0.65% | Add +59.5% | 1,020,206 | $40.2M |
| Baker Bros. Advisors LP | 0.41% | No change | 993,679 | $39.1M |
| JPMorgan Chase & Co. | 0.00% | Add +1263.2% | 976,783 | $38.5M |
| Orbimed Advisors LLC | 0.66% | Add +5.7% | 911,420 | $35.9M |
| Vestal Point Capital, LP | 2.56% | Add +57.1% | 825,000 | $32.5M |
| Avidity Partners Management LP | 1.64% | Add +8.5% | 818,000 | $32.2M |
| TimesSquare Capital Management, LLC | 0.46% | Add +3.1% | 778,293 | $30.6M |
| Siren, L.L.C. | 1.47% | — | 743,769 | $29.3M |
| Federated Hermes, Inc. | 0.06% | Add +0.2% | 736,200 | $29.0M |
| Citadel Advisors | 0.03% | Reduce -6.0% | 722,504 | $28.4M |
| Loomis Sayles & Co. L P | 0.04% | Add +7.1% | 707,222 | $27.8M |
| Westfield Capital Management Co. LP | 0.12% | Add +4.0% | 669,600 | $26.4M |
| Franklin Resources Inc. | 0.01% | Reduce -2.2% | 565,915 | $23.6M |
| Boxer Capital, LLC | 1.16% | No change | 600,000 | $23.6M |
| Jennison Associates LLC | 0.01% | Add +1.1% | 576,661 | $22.7M |
| Fiera Capital Corp | 0.07% | Reduce -4.9% | 554,200 | $21.8M |
| Perceptive Advisors LLC | 0.44% | Reduce -10.0% | 524,930 | $20.7M |
| Candriam S.C.A. | 0.11% | Reduce -11.1% | 463,861 | $18.3M |
| Goldman Sachs Group Inc. | 0.00% | Add +26.2% | 459,625 | $18.1M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.04% | Add +4.3% | 439,074 | $17.3M |
| Point72 Asset Management | 0.05% | Reduce -20.5% | 383,290 | $15.1M |
| Altium Capital Management LLC | 4.24% | No change | 360,600 | $14.2M |
| Vanguard Group Inc. | 0.00% | Add +0.9% | 344,365 | $13.6M |
| First Turn Management, LLC | 2.03% | Reduce -4.3% | 325,218 | $12.8M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -31.3% | 299,865 | $11.8M |
| Alyeska Investment Group, L.P. | 0.06% | Reduce -1.0% | 288,843 | $11.4M |
| State Street Corp. | 0.00% | Add +13.3% | 279,513 | $11.0M |
| DAFNA Capital Management LLC | 2.57% | No change | 273,739 | $10.8M |
| Two Sigma Advisers, LP | 0.03% | Add +31.0% | 273,700 | $10.8M |
| ExodusPoint Capital Management, LP | 0.11% | Reduce -26.5% | 262,631 | $10.3M |
| Aberdeen Group plc | 0.02% | Add +16.9% | 248,311 | $9.8M |
| Two Sigma Investments, LP | 0.02% | Add +24.8% | 243,579 | $9.6M |
| Morgan Stanley | 0.00% | Add +0.5% | 239,942 | $9.4M |
| Russell Investments Group, Ltd. | 0.01% | Add +37.3% | 223,614 | $8.8M |
| Algert Global LLC | 0.23% | Add +19.9% | 219,645 | $8.6M |
| Invesco Ltd. | 0.00% | Reduce -75.1% | 215,822 | $8.5M |
| Assenagon Asset Management S.A. | 0.02% | Add +188.4% | 212,287 | $8.4M |
| Ally Bridge Group (NY) LLC | 4.46% | Add +25.1% | 211,791 | $8.3M |
| Millennium Management | 0.01% | Add +19.1% | 209,026 | $8.2M |
| D. E. Shaw & Co. | 0.01% | Add +26.7% | 204,892 | $8.1M |
| Granahan Investment Management, LLC | 0.31% | Reduce -11.2% | 200,877 | $7.9M |
| Parkman Healthcare Partners LLC | 0.96% | Reduce -8.4% | 191,658 | $7.5M |
| DNB Asset Management AS | 0.03% | Add +8.5% | 190,623 | $7.5M |
| AXA S.A. | 0.02% | Add +0.0% | 188,090 | $7.4M |
| PFM Health Sciences, LP | 0.41% | Add +19.5% | 179,878 | $7.1M |
| Lord, Abbett & Co. LLC | 0.02% | Reduce -8.4% | 173,985 | $6.8M |
| Schroder Investment Management Group | 0.01% | Add +93.1% | 176,674 | $6.8M |
| MPM Bioimpact LLC | 0.98% | New | 165,800 | $6.5M |
| Ensign Peak Advisors, Inc | 0.01% | No change | 163,064 | $6.4M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +0.1% | 162,683 | $6.4M |
| Bridger Management, LLC | 2.89% | No change | 146,800 | $5.8M |
| New York State Common Retirement Fund | 0.01% | Reduce -12.1% | 132,521 | $5.2M |
| Bank of America Corp. | 0.00% | Reduce -10.4% | 127,456 | $5.0M |
| Atika Capital Management LLC | 0.53% | Add +1.6% | 126,000 | $5.0M |
| Swiss National Bank | 0.00% | Reduce -0.6% | 125,300 | $4.9M |
| Ikarian Capital, LLC | 1.31% | No change | 107,187 | $4.2M |
| Nan Fung Group Holdings Ltd | 3.62% | No change | 106,680 | $4.2M |
| Walleye Capital LLC | 0.05% | New | 104,960 | $4.1M |
| State of Wisconsin Investment Board | 0.01% | Add +12.4% | 100,982 | $4.0M |
| Baron Capital (BAMCO) | 0.01% | No change | 100,100 | $3.9M |
| Balyasny Asset Management L.P. | 0.01% | Reduce -63.9% | 84,198 | $3.3M |
| HighVista Strategies LLC | 1.00% | Add +1.4% | 73,762 | $2.9M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.2% | 68,809 | $2.7M |
| Jefferies Financial Group Inc. | 0.05% | Reduce -3.6% | 66,500 | $2.6M |
| Ameriprise Financial Inc. | 0.00% | New | 66,383 | $2.6M |
| Wells Fargo & Company | 0.00% | Add +2.4% | 60,456 | $2.4M |
| Alps Advisors Inc. | 0.01% | Reduce -3.2% | 56,989 | $2.2M |
| California State Teachers Retirement System | 0.00% | Reduce -3.7% | 56,004 | $2.2M |
| Legal & General Group Plc | 0.00% | No change | 55,120 | $2.2M |
| Moore Capital Management, LP | 0.07% | No change | 55,000 | $2.2M |
| Deutsche Bank AG | 0.00% | No change | 53,711 | $2.1M |
| Erste Asset Management GmbH | 0.02% | No change | 50,000 | $1.9M |
| Bank of New York Mellon Corp | 0.00% | Reduce -4.6% | 48,891 | $1.9M |
| Envestnet Asset Management Inc. | 0.00% | Reduce -0.2% | 48,836 | $1.9M |
| LMR Partners LLP | 0.05% | No change | 48,668 | $1.9M |
| State of New Jersey Common Pension Fund D | 0.01% | No change | 48,573 | $1.9M |
| Harbor Capital Advisors, Inc. | 0.08% | Add +99.3% | 48,063 | $1.9M |
| Voya Investment Management LLC | 0.00% | No change | 47,165 | $1.9M |
| Jump Financial, LLC | 0.04% | Reduce -6.6% | 45,000 | $1.8M |
| Renaissance Technologies | 0.00% | Reduce -52.6% | 44,000 | $1.7M |
| Northern Trust Corp. | 0.00% | Reduce -7.4% | 43,406 | $1.7M |
"% of holder's portfolio" is XENE's weight in each manager's 13F, not the share of Xenon Pharmaceuticals Inc. the manager owns.